916 results match your criteria: "and University Health Network[Affiliation]"
Simul Healthc
December 2024
ASPE President, 2024-2025, Past ASPE Grants & Research Committee Chair, Executive Director, M Simulation, Associate Professor, Medicine, University of Minnesota (L.C.), Minneapolis, MN; Senior Postdoctoral Fellow, Honorary Lecturer, RCSI SIM Centre for Simulation Education and Research (A.D.), Dublin, Ireland; Assistant Dean for IPE, School of Health Sciences, Springfield College (M.E.), Springfield, MA; Past ASPE Grants & Research Committee Chair, Communication Matters: INESRA, Assistant Professor, Institute of Health Policy, Management and Evaluation, University of Toronto, Scientist, The Wilson Centre for Research in Education, University of Toronto and University Health Network (N.M.), Toronto, Canada; Past ASPE Grants & Research Committee Chair, Associate Professor Emeritus, OB/GYN, Director of Simulation Education and Operations (ret.), Clinical Simulation Laboratory, University of Vermont (C.N.), Burlington, VT; ASPE Past President, 2008-2009, Founding Director, Simulation and Clinical Skills Center, Chair, Interprofessional Education Committee, Faculty, Department of Community and Family Medicine, Howard University (T.O.), Washington, DC; Interprofessional & Simulation Educator, Baycrest Academy for Research and Education at Baycrest Centre for Geriatric Care (C.S.), Toronto, Canada; Past ASPE Grants & Research Committee Chair, Assistant Dean, Educational Affairs, Professor, Department of Internal Medicine, Distinguished Teaching Professor, University of Texas Medical Branch (K.S.), Galveston, TX; ASPE Grants & Research Committee Chair, 2024-2025, Associate Director of Educational Measurement Research and Development, Office of Consultation & Research in Medical Education, Clinical Assistant Professor, Department of Family Medicine, Carver College of Medicine, University of Iowa (K.X.), Iowa City, IA; and Professor of Simulation Education in Healthcare, School of Clinical Sciences, Faculty of Medicine, Nursing & Health Sciences, Monash University (D.N.), Clayton, Australia.
Rheumatology (Oxford)
December 2024
The Center for Autoimmune, Musculoskeletal and Hematopoietic Diseases, The Feinstein Institutes for Medical Research, Manhasset, NY, USA.
Objective: Evaluate the efficacy and safety of guselkumab, an interleukin (IL)-23 inhibitor, in a Phase 2, multicentre, randomized, double-blind, placebo-controlled study of patients with active lupus nephritis (LN).
Methods: Adults (18-75 years) with active LN (Class III-IV proliferative nephritis [kidney biopsy] and urine protein-to-creatinine ratio [UPCR)] of ≥ 1 mg/mg despite standard-of-care therapy) were randomized (1:1; planned sample = 60) to receive intravenous infusions of guselkumab 400 mg or placebo at Weeks 0, 4, and 8, then subcutaneous injections (guselkumab 200 mg or placebo) at Week12 and every 4 weeks through Week48 in addition to their background therapy. The primary end point was achievement of ≥ 50% decrease in proteinuria from baseline at Week24.
HIV Med
December 2024
Division of Geriatric Medicine, Department of Medicine, Sinai Health System and University Health Network, Toronto, Ontario, Canada.
Objectives: HIV is often under-recognized in older individuals, particularly women, despite a significant number of new cases being diagnosed in those aged >50 years. This review aimed to understand the age-related experiences and challenges faced by women aged ≥50 years living with HIV through an intersectional perspective.
Methods: We conducted a systematic scoping review using the framework by Arksey and O'Malley, refined by Levac, Colquhoun, and Peters, and informed by a Sex- and Gender-Based Analysis Plus (SGBA+) approach.
Mol Psychiatry
December 2024
Univ. Lille, Inserm, CHU Lille, Institut Pasteur de Lille, LabEx DISTALZ - U1167-RID-AGE Facteurs de Risque et Déterminants Moléculaires des Maladies Liées au Vieillissement, Lille, France.
JMIR Aging
December 2024
Section of Geriatric Medicine, Department of Medicine, Sinai Health System and University Health Network, Toronto, ON, Canada.
Background: As the population of individuals with HIV ages rapidly due to advancements in antiretroviral therapy, virtual care has become an increasingly vital component in managing their complex health needs. However, little is known about perceptions of virtual care among older adults living with HIV.
Objective: This study aimed to understand the perceptions of older adults living with HIV regarding virtual care.
PLoS One
December 2024
Section of Geriatric Medicine, Department of Medicine, Sinai Health System and University Health Network, Toronto, Toronto, Ontario, Canada.
Background And Objectives: End-of-life care supports individuals in the last few weeks or months of their life and their caregivers, offering psychosocial support, symptom management and relief, and resources. While some of the first public end-of-life care facilities were established due to HIV/AIDS, the current needs of caregivers for people living with end-stage HIV are not well understood. Caregivers provide two-thirds of the care for people living with HIV, yet their specific support needs and experiences are under-researched.
View Article and Find Full Text PDFBioorg Med Chem
January 2025
Krembil Research Institute, University Health Network, Toronto, Ontario, Canada; Centre for Cannabinoid Therapeutics, University of Toronto and University Health Network, Toronto, Ontario, Canada; Department of Pharmaceutical Sciences, Leslie Dan Faculty of Pharmacy, University of Toronto, Ontario, Canada. Electronic address:
Cannabidiol (CBD), a bicyclic non-psychoactive cannabinoid biosynthesized by Cannabis spp. of plants, has attracted significant interest in the past decade due to its therapeutic properties. In 2018, the US FDA approved Epidiolex®, a CBD-based drug for the treatment of two rare epileptic seizure disorders.
View Article and Find Full Text PDFVaccines (Basel)
October 2024
Medical Affairs Americas, CSL Seqirus, Montreal, QC H9H 4M7, Canada.
We conducted a cross-sectional, online survey of adult Canadian residents to evaluate their attitudes and beliefs about vaccination against respiratory viruses, particularly influenza and coronavirus 2019 (COVID-19). Survey participants aged ≥ 18 years were randomly recruited from the Léger Opinion (LEO) consumer panel. Out of 3002 respondents, 76% reported being "up-to-date" on all of their recommended vaccinations, 86% reported understanding why the influenza vaccine was needed annually, 79% reported believing the influenza vaccine was safe, and 83% reported understanding that vaccines, in general, were important for health.
View Article and Find Full Text PDFNucl Med Biol
November 2024
Department of Pharmaceutical Sciences, University of Toronto, Toronto, ON, Canada; Department of Medical Imaging, University of Toronto, Toronto, ON, Canada; Laboratory Medicine Program, University Health Network, Toronto, ON, Canada. Electronic address:
Introduction: Our objective was to study convection enhanced delivery (CED) of Lu-labeled metal chelating polymer (MCP) conjugated to gold nanoparticles ([Lu]Lu-MCP-AuNP) alone or combined with anti-PD1 immune checkpoint inhibition (ICI) for improving the survival of immunocompetent C57BL/6J mice with orthotopic GL261 murine glioma tumors.
Methods: C57BL/6J mice with GL261 tumors were treated with [Lu]Lu-MCP-AuNP (0.8 or 2.
Intensive Care Med
December 2024
Department of Medicine, Interdepartmental Division of Critical Care Medicine, Sinai Health System and University Health Network, University of Toronto, Toronto, Canada.
Purpose: The optimal physiologic parameters to monitor after a session of awake prone positioning in patients with acute respiratory failure are not well understood. This study aimed to identify which early physiologic changes after the first session of awake prone positioning are linked to the need for invasive mechanical ventilation or death in patients with acute respiratory failure.
Methods: We performed a secondary analysis of a prospective cohort study of adult patients with acute respiratory failure related to coronavirus disease 2019 (COVID-19) treated with awake prone positioning.
Lancet Healthy Longev
November 2024
Infectious Diseases Department of Medicine, University of Toronto, Toronto, ON, Canada; Infectious Diseases, Department of Medicine, University Health Network, Toronto, ON, Canada; Canadian Institutes of Health Research, Canadian HIV Trails Network, Vancouver, BC, Canada.
Lancet Reg Health Am
November 2024
Institute of Health Policy, Management and Evaluation, University of Toronto, Toronto, Ontario, Canada.
Background: People with disabilities are at elevated risk of adverse short-term outcomes following hospitalization for acute infectious illness. No prior studies have compared long-term healthcare use among this high-risk population. We compared the healthcare use of adults with disabilities in the one year following hospitalization for COVID-19 vs.
View Article and Find Full Text PDFRes Dev Disabil
November 2024
Department of Occupational Science and Occupational Therapy, University of Toronto, Canada; KITE-Toronto Rehabilitation Institute, University Health Network, Canada; Rehabilitation Sciences Institute, University of Toronto, Canada; Section of Geriatric Medicine, Sinai Health and University Health Network, Canada. Electronic address:
Background: Advances in medicine have increased the life expectancy of adults with neurodevelopmental disabilities (ND). These individuals often reside with aging family caregivers, who also experience age-related health issues. However, many caregivers lack future care plans for their adult children.
View Article and Find Full Text PDFJAMA Netw Open
October 2024
Department of Medicine, University of Toronto, Toronto, Ontario, Canada.
PLoS One
October 2024
Faculty of Liberal Arts, Wilfred Laurier University, Brantford, Canada.
Introduction: The pursuit of Equity, Diversity and Inclusion (EDI) in healthcare education has garnered significant attention in recent years, reflecting a broader societal imperative for equitable healthcare delivery. However, existing curricula within geriatric healthcare education may not adequately address these diverse needs within their educational frameworks, inadvertently resulting in disparities in care delivery and outcomes. Within the realm of geriatric healthcare, addressing EDI is particularly crucial due to the diverse needs of older adult populations and the imperative for healthcare professionals to deliver culturally humble care.
View Article and Find Full Text PDFPLoS One
October 2024
Division of Geriatric Medicine, Department of Medicine, Sinai Health System and University Health Network, Toronto, Ontario, Canada.
BMC Geriatr
September 2024
Centre de Recherche Intégrée Pour Un Système Apprenant en Santé Et Services Sociaux, Centre Intégré de Santé Et Services Sociaux de Chaudière-Appalaches, Lévis, Québec, Canada.
Objective: Improving care transitions for older adults can reduce emergency department (ED) revisits, and the strain placed upon caregivers. We analyzed whether caregivers felt a change in burden following a care transition, and what may be improved to reduce it.
Methods: This mixed-methods observational study nested within LEARNING WISDOM included caregivers of older patients who experienced an ED care transition.
J Cosmet Dermatol
September 2024
School of Pharmacy, BRAC University, Dhaka, Bangladesh.
Background: Low-dose oral minoxidil (LDOM) is used to treat hair loss, but the literature on its safety profile is relatively sparse.
Aims: Using the FDA Adverse Event Reporting System (FAERS) database, we determined signals for adverse events (AEs) with LDOM use.
Methods: Four sets of case/noncase study disproportionality analyses were conducted to determine reporting odds ratio (ROR) for 10 AEs including pericardial effusion (PE).
Healthc Pap
July 2024
Professor of Medicine, Division of Geriatric Medicine, Department of Medicine, University of Toronto, Director of Health Policy Research, National Institute on Ageing, Toronto Metropolitan University, Toronto, ON.
The evolving concept of "[a]geing in the right place (AIRP)" (Iciaszczyk et al. 2022: 1) underscores the importance of enabling older adults to receive comprehensive care and support across various settings. There is growing evidence that innovative technologies can empower more persons to maintain their autonomy while better ensuring their safety, well-being and quality of life and also improve the experience of family caregivers and paid care providers.
View Article and Find Full Text PDFHealthc Pap
July 2024
Professor of Medicine, Division of Geriatric Medicine, Department of Medicine, University of Toronto, Director of Health Policy Research, National Institute on Ageing, Toronto Metropolitan University, Toronto, ON.
This paper explores the rapidly growing integration of technology in the delivery of health and social care specifically focused on enabling "Ageing in the Place" (AIRP) (Iciaszczyk et al. 2022: 1). While exploring emerging opportunities and challenges, it specifically highlights growing disparities that are creating , as well as ethical concerns that will need to be addressed and supported by comprehensive evaluation frameworks and policies.
View Article and Find Full Text PDFClin J Am Soc Nephrol
August 2024
Division of Nephrology and Hypertension, Mayo Clinic, Rochester, Minnesota.
Ann Surg Open
September 2024
Division of Urology, Department of Surgery, University of Toronto, Toronto, ON, Canada.
Can Med Educ J
August 2024
Academics Program, Women's College Hospital, Ontario, Canada.
J Stroke Cerebrovasc Dis
November 2024
Department of Neurology, Queen's University, Ontario, Canada.
Background: Carotid web is a thin shelf-like fibrointimal membrane arising from the posterior or posterolateral wall of the carotid bulb. Webs cause stroke, especially in younger adults with high risk of recurrence.
Methods: To report the first case of de-novo formation of an asymptomatic carotid web and describe longitudinal clinical-angiographic follow-up.
J Head Trauma Rehabil
September 2024
Author Affiliations: Parkwood Institute Research, Lawson Research Institute London, Ontario, (Drs MacKenzie, Teasell, and Mehta); Department of Physical Medicine and Rehabilitation, Schulich School of Medicine and Dentistry, Western University, London, Ontario (Drs MacKenzie, Teasell, and Mehta); Department of Physical Medicine and Rehabilitation, Parkwood Institute, St. Joseph's Health Care London, London, Ontario (Drs MacKenzie and Teasell) Acquired Brain Injury Program, Hamilton Health Sciences, Hamilton, Ontario, and Department of Psychiatry and Behavioural Neurosciences, DeGroote School of Medicine, McMaster University, Hamilton, Ontario (Dr Velikonja); Schulich School of Medicine and Dentistry, Western University, London, Ontario (Mss J. Devito and L. Devito); Rehabilitation Sciences Institute, University of Toronto, Toronto, Ontario (Ms Patsakos); KITE Research Institute, Toronto Rehabilitation Institute-University Health Network, Toronto, Ontario (Ms Patsakos and Dr Bayley); and Division of Physical Medicine and Rehabilitation, Temerty Faculty of Medicine, University of Toronto, Toronto, Ontario and University Health Network, Toronto Rehabilitation Institute, Toronto, Ontario (Bayley).
Objective: Behavioral changes following moderate to severe traumatic brain injury (MSTBI) are common and can include agitation or aggression, reduced arousal or apathy, and inappropriate sexual behavior. These changes can negatively affect recovery, function, and quality of life. Pharmacological and nonpharmacological interventions are often used to address these challenges; however, there is limited evidence regarding the effectiveness of these treatments.
View Article and Find Full Text PDF